A detailed history of Nuveen Asset Management, LLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 115,122 shares of PLSE stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115,122
Previous 60,336 90.8%
Holding current value
$2.09 Million
Previous $675,000 199.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.83 - $21.83 $593,332 - $1.2 Million
54,786 Added 90.8%
115,122 $2.02 Million
Q2 2024

Aug 09, 2024

BUY
$6.69 - $14.54 $227,219 - $493,836
33,964 Added 128.79%
60,336 $675,000
Q4 2023

Feb 14, 2024

BUY
$3.85 - $12.84 $13,886 - $46,313
3,607 Added 15.84%
26,372 $322,000
Q3 2023

Nov 14, 2023

SELL
$4.03 - $8.73 $15,265 - $33,069
-3,788 Reduced 14.27%
22,765 $91,000
Q2 2023

Aug 14, 2023

BUY
$3.67 - $8.64 $97,449 - $229,417
26,553 New
26,553 $190,000
Q2 2022

Aug 15, 2022

SELL
$1.48 - $4.28 $54,119 - $156,506
-36,567 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$17.25 - $26.63 $78,711 - $121,512
-4,563 Reduced 11.09%
36,567 $836,000
Q2 2021

Aug 16, 2021

SELL
$16.31 - $23.64 $193,175 - $279,992
-11,844 Reduced 22.36%
41,130 $675,000
Q1 2021

May 17, 2021

SELL
$22.43 - $44.27 $195,970 - $386,786
-8,737 Reduced 14.16%
52,974 $1.25 Million
Q4 2020

Feb 16, 2021

SELL
$11.66 - $24.5 $65,529 - $137,690
-5,620 Reduced 8.35%
61,711 $1.47 Million
Q3 2020

Nov 16, 2020

BUY
$9.27 - $13.14 $3,068 - $4,349
331 Added 0.49%
67,331 $793,000
Q2 2020

Aug 14, 2020

BUY
$6.23 - $13.09 $165,749 - $348,259
26,605 Added 65.86%
67,000 $701,000
Q1 2020

May 14, 2020

SELL
$5.23 - $15.2 $1,124 - $3,268
-215 Reduced 0.53%
40,395 $289,000
Q3 2019

Nov 14, 2019

SELL
$10.73 - $17.33 $23,219 - $37,502
-2,164 Reduced 5.06%
40,610 $627,000
Q2 2019

Aug 15, 2019

BUY
$11.11 - $17.34 $475,219 - $741,701
42,774 New
42,774 $564,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $675M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.